What are the items of the Cambridge‑Hopkins Restless Legs Syndrome questionnaire (CH‑RLSq)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cambridge-Hopkins Questionnaire for Restless Legs Syndrome (CH-RLSq)

The Cambridge-Hopkins diagnostic questionnaire (CH-RLSq) is a 13-item self-completed screening tool that evaluates the 4 core diagnostic criteria of RLS while systematically excluding common mimics such as positional discomfort and leg cramps. 1

Core Structure and Purpose

The CH-RLSq was specifically designed to enable large-scale RLS diagnosis without requiring a trained interviewer, making it particularly valuable for epidemiological studies and population-based screening. 1

The 13 Questions Address:

  • The 4 essential diagnostic criteria for RLS: 1

    • Urge to move the legs, usually accompanied by uncomfortable sensations
    • Symptoms that begin or worsen during rest or inactivity
    • Symptoms partially or totally relieved by movement
    • Symptoms worse in the evening or at night than during the day
  • Differential diagnosis items to exclude RLS mimics: 1

    • Positional discomfort (symptoms that resolve simply by changing position without continued movement)
    • Leg cramps (sudden, painful muscle contractions)

Validation and Performance Characteristics

The CH-RLSq demonstrates strong psychometric properties when validated against expert clinical diagnosis: 2

  • Sensitivity: 87.2% for detecting true RLS cases 2
  • Specificity: 94.4% for correctly identifying non-RLS individuals 2
  • Positive predictive value: 85.5% in population-based samples 2

The questionnaire has been validated across multiple populations, including an Arabic translation showing 71% sensitivity and 100% specificity in Lebanese populations. 3

Clinical Recommendation Status

The American Academy of Sleep Medicine classifies the CH-RLSq as a "Recommended" diagnostic tool because it meets all three Movement Disorder Society criteria: 1

  1. Utilized in appropriate RLS patient populations
  2. Applied by multiple independent research teams beyond the original developers
  3. Demonstrates excellent clinimetric properties in validation studies

Practical Advantages

  • Self-administered format eliminates the need for trained interviewers, reducing cost and time burden 1
  • Systematic mimic exclusion built into the questionnaire structure improves diagnostic accuracy compared to simple symptom checklists 1
  • Validated for population surveys where individual clinical interviews would be impractical 2

Important Caveats

While the CH-RLSq provides excellent screening capability, it remains a questionnaire-based tool rather than a definitive clinical diagnosis. 1 Positive screens should prompt clinical evaluation, particularly to assess iron status (ferritin ≤100 ng/mL or transferrin saturation <20%), identify exacerbating medications, and evaluate for associated conditions like end-stage kidney disease, pregnancy, or peripheral neuropathy. 4

The questionnaire's strength lies in its balance between comprehensive diagnostic coverage and practical feasibility for large-scale use, making it superior to single-question screeners while avoiding the 45-minute administration time required by telephone diagnostic interviews. 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.